| Tretinoin | Approved Investigational Nutraceutical | MAGEB3 | 4114 |
upregulated | Tretinoin results in increased expression of MAGEB3 mRNA | Xp21.2 | |
| Tretinoin | Approved Investigational Nutraceutical | MAGEH1 | 28986 |
upregulated | Tretinoin results in increased expression of MAGEH1 mRNA | Xp11.21 | |
| Tretinoin | Approved Investigational Nutraceutical | MAGI1 | 9223 |
downregulated | Tretinoin results in decreased expression of MAGI1 mRNA | 3p14.1 | |
| Tretinoin | Approved Investigational Nutraceutical | MAGI2 | 9863 |
upregulated | Tretinoin results in increased expression of MAGI2 mRNA | 7q21.11 | |
| Tretinoin | Approved Investigational Nutraceutical | MAGOH | 4116 |
downregulated | Tretinoin results in decreased expression of MAGOH mRNA | 1p32.3 | |
| Tretinoin | Approved Investigational Nutraceutical | MAL | 4118 |
downregulated | Tretinoin results in decreased expression of MAL mRNA | 2q11.1 | |
| Tretinoin | Approved Investigational Nutraceutical | MAL2 | 114569 |
upregulated | Tretinoin results in increased expression of MAL2 mRNA | 8q24.12 | |
| Tretinoin | Approved Investigational Nutraceutical | MALAT1 | 378938 |
upregulated | Tretinoin results in increased expression of MALAT1 mRNA | 11q13.1 | |
| Tretinoin | Approved Investigational Nutraceutical | MAN1A1 | 4121 |
upregulated | Tretinoin results in increased expression of MAN1A1 mRNA | 6q22.31 | |
| Tretinoin | Approved Investigational Nutraceutical | MAN1A2 | 10905 |
upregulated | Tretinoin results in increased expression of MAN1A2 mRNA | 1p12 | |
| Tretinoin | Approved Investigational Nutraceutical | MAN1C1 | 57134 |
upregulated | Tretinoin results in increased expression of MAN1C1 mRNA | 1p36.11 | |
| Tretinoin | Approved Investigational Nutraceutical | MANEAL | 149175 |
upregulated | Tretinoin results in increased expression of MANEAL mRNA | 1p34.3 | |
| Tretinoin | Approved Investigational Nutraceutical | MANSC1 | 54682 |
upregulated | Tretinoin results in increased expression of MANSC1 mRNA | 12p13.2 | |
| Tretinoin | Approved Investigational Nutraceutical | MAOA | 4128 |
downregulated | Tretinoin results in decreased expression of MAOA mRNA | Xp11.3 | |
| Tretinoin | Approved Investigational Nutraceutical | MAP1B | 4131 |
downregulated | Tretinoin results in decreased expression of MAP1B mRNA | 5q13.2 | |
| Tretinoin | Approved Investigational Nutraceutical | MAP2 | 4133 |
downregulated | Tretinoin results in decreased expression of MAP2 mRNA | 2q34 | |
| Tretinoin | Approved Investigational Nutraceutical | MAP2 | 4133 |
upregulated | Tretinoin results in increased expression of MAP2 mRNA | 2q34 | |
| Tretinoin | Approved Investigational Nutraceutical | MAP2K6 | 5608 |
downregulated | Tretinoin results in decreased expression of MAP2K6 mRNA | 17q24.3 | |
| Tretinoin | Approved Investigational Nutraceutical | MAP3K1 | 4214 |
upregulated | Tretinoin results in increased expression of MAP3K1 mRNA | 5q11.2 | |
| Tretinoin | Approved Investigational Nutraceutical | MAP3K14 | 9020 |
upregulated | Tretinoin results in increased expression of MAP3K14 mRNA | 17q21.31 | |
| Tretinoin | Approved Investigational Nutraceutical | MAP3K5 | 4217 |
upregulated | Tretinoin results in increased expression of MAP3K5 mRNA | 6q23.3 | |
| Tretinoin | Approved Investigational Nutraceutical | MAP3K8 | 1326 |
upregulated | Tretinoin results in increased expression of MAP3K8 mRNA | 10p11.23 | |
| Tretinoin | Approved Investigational Nutraceutical | MAP4K5 | 11183 |
downregulated | Tretinoin results in decreased expression of MAP4K5 mRNA | 14q22.1 | |
| Tretinoin | Approved Investigational Nutraceutical | MAP4K5 | 11183 |
upregulated | Tretinoin results in increased expression of MAP4K5 mRNA | 14q22.1 | |
| Tretinoin | Approved Investigational Nutraceutical | MAP6 | 4135 |
downregulated | Tretinoin results in decreased expression of MAP6 mRNA | 11q13.5 | |